These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 33950779

  • 21. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
    Liu YF, Renk E, Rauch SD, Xu HX.
    Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472
    [Abstract] [Full Text] [Related]

  • 22. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
    Gabra N, Saliba I.
    Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
    [Abstract] [Full Text] [Related]

  • 23. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A, Aloisi A, De Benedittis G, Scaringi A.
    Ann N Y Acad Sci; 1999 Nov 28; 884():410-24. PubMed ID: 10842610
    [Abstract] [Full Text] [Related]

  • 24. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W, Szyfter W, Lączkowska-Przybylska J, Szyfter-Harris J.
    Otolaryngol Pol; 2012 Nov 28; 66(1):20-6. PubMed ID: 22381010
    [Abstract] [Full Text] [Related]

  • 25. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun 28; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 26. CASP9 genotype confers gentamicin susceptibility in intratympanic treatment of intractable vertigo caused by Ménière's disease.
    Huang CJ, Wan TK, Fang TY, Wang PC.
    Acta Otolaryngol; 2019 Apr 28; 139(4):336-339. PubMed ID: 30907242
    [Abstract] [Full Text] [Related]

  • 27. Role of prior intratympanic gentamicin and corticosteroids therapy on speech understanding in patients with Menière's disease after cochlear implantation.
    Thangavelu K, Gillhausen F, Weiß RM, Mueller-Mazzotta J, Stuck BA, Reimann K.
    Eur Arch Otorhinolaryngol; 2024 Jul 28; 281(7):3483-3490. PubMed ID: 38302621
    [Abstract] [Full Text] [Related]

  • 28. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
    Patel M, Agarwal K, Arshad Q, Hariri M, Rea P, Seemungal BM, Golding JF, Harcourt JP, Bronstein AM.
    Lancet; 2016 Dec 03; 388(10061):2753-2762. PubMed ID: 27865535
    [Abstract] [Full Text] [Related]

  • 29. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
    Büki B, Platz M, Haslwanter T, Jünger H, Avan P.
    Audiol Neurootol; 2011 Dec 03; 16(1):49-54. PubMed ID: 20523039
    [Abstract] [Full Text] [Related]

  • 30. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease.
    Harcourt JP, Lambert A, Wong PY, Patel M, Agarwal K, Golding JF, Bronstein AM.
    Otol Neurotol; 2019 Apr 03; 40(4):491-496. PubMed ID: 30870364
    [Abstract] [Full Text] [Related]

  • 31. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K, Schönfeld U, Clarke AH.
    Laryngoscope; 2007 Dec 03; 117(12):2244-50. PubMed ID: 17909448
    [Abstract] [Full Text] [Related]

  • 32. Long-term Vertigo Control and Vestibular Function After Low-dose On-demand Transtympanic Gentamicin for Refractory Menière's Disease.
    Nicolas S, Kmeid M, Mansour C, Fraysse B, Deguine O, Marx M, Fraysse ME.
    Otol Neurotol; 2019 Feb 03; 40(2):218-225. PubMed ID: 30624404
    [Abstract] [Full Text] [Related]

  • 33. Consensus on intratympanic drug delivery for Menière's disease.
    Li S, Pyykkö I, Zhang Q, Yang J, Duan M.
    Eur Arch Otorhinolaryngol; 2022 Aug 03; 279(8):3795-3799. PubMed ID: 35469039
    [Abstract] [Full Text] [Related]

  • 34. Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study.
    Liu B, Leng Y, Zhou R, Liu J, Liu D, Zhang SL, Kong WJ.
    Medicine (Baltimore); 2016 Dec 03; 95(52):e5767. PubMed ID: 28033296
    [Abstract] [Full Text] [Related]

  • 35. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr 03; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 36. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN, Akkuzu G, Ozgirgin N, Tarhan E.
    Acta Otolaryngol; 2008 Apr 03; 128(4):422-6. PubMed ID: 18368577
    [Abstract] [Full Text] [Related]

  • 37. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K, Krzeska-Malinowska I, Kowalska M, Bartoszewicz R, Niemczyk K.
    Otolaryngol Pol; 2005 Apr 03; 59(3):409-13. PubMed ID: 16117399
    [Abstract] [Full Text] [Related]

  • 38. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K, Ata N.
    Am J Otolaryngol; 2019 Apr 03; 40(5):711-714. PubMed ID: 31262549
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.
    Abou-Halawa AS, Poe DS.
    Otol Neurotol; 2002 Jul 03; 23(4):494-502; discussion 502-3. PubMed ID: 12170152
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.